Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Exponent, Inc.

Exponent is a scientific and engineering consulting firm that provides solutions for complex problems across diverse industries, including accident investigation and regulatory compliance. Self-described as having unrivaled experience and resources to solve scientific and engineering challenges.

Exponent

Exponent | 35,949 followers on LinkedIn. Premium Engineering &amp; Scientific Consulting | In an era of accelerating change, Exponent is the only premium engineering and scientific consulting firm with the depth and breadth of expertise to solve our clients’ most profoundly unique, unprecedented, and urgent challenges.

Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, sustainable world.  

Our consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent&#39;s offices in North America, Asia, and Europe.

Brad James

Troy Morgan

Head of Cosmetic Safety and Regulatory Affairs at Exponent

Iain Brunning

Consultant in corrosion, failure analysis, corrosion, metallurgy, fracture, and material science

Larry Eiselstein

The Food Safety Modernization Act (FSMA) expanded on Hazard Analysis Critical Control Point (HACCP) principles by shifting the focus from reactive to proactive prevention strategies. Comprehensive food safety systems address not only microbiological hazards but also physical and chemical hazards. How can companies recognize emerging issues or perform a hazard analysis on heavy metals or potentially toxic elements? At National Capital Area Regional Chapter of the Society of Toxicology Fall 2024 Virtual Symposium, Exponent’s Taryn Horr, CFS, CCFS , will present “FSMA Focus: Safeguarding Against Toxic Risks” on Thursday, Nov. 14, 11:25-11:45 a.m. EST. Ms. Horr will address the challenges companies face in identifying chemical hazards, defining acceptable levels in products, utilizing good manufacturing practices (GMPs), and applying supply chain controls. This presentation will suggest how companies can identify chemical risks through hazard analysis and will provide case studies around heavy metals in baby foods and importing novel ingredients/GRAS status. Register: https://hubs.li/Q02Y0j9J0 Connect with Ms. Horr: https://hubs.li/Q02Y0lRT0 #Exponent #Event #ChemicalRegulation #FoodSafety #FSMA #HACCP

The causes of vehicle accidents are manifold and complex. Alongside industry peers, Exponent consultants have published a report with National Academies Press that helps traffic safety practitioners diagnose the contributing factors to vehicle crashes, as well as identify potential countermeasures and technologies available to address these crashes. Learn how this free toolbox contributes critical insights to improving road safety — reflecting the type of independent, real-world research Exponent brings to diverse transportation clients and their challenges: https://hubs.li/Q02Y0ndH0 John Campbell , Chris Monk , Audra (Krake) Fraser, MS , Liberty Hoekstra-Atwood #Exponent #WhatCanWeHelpYouSolve #Transportation #TrafficSafety #AccidentInvestigation #IncidentResponse

We're #hiring a new Sr. Managing Engineer ADAS/AV/EV (MS/PhD) in Los Angeles County, California. Apply today or share this post with your network.

Mega construction projects across a variety of industries are planned throughout the Middle East — many of which aim to showcase the region’s commitment to innovation and clean energy while operating in one of the most demanding environments in the world. Success will largely depend on how the complex technologies, equipment, and systems in these facilities come together. Read why multidisciplinary technical expertise is the best bet for bringing complex industrial plants online — and how careful contracting and key testing milestones can help reduce claims and disputes along the way: https://hubs.li/Q02X_Y600 Shane Kennett, PhD,PE,CWI , Kaitlin Spak, PhD, PE #WhatCanWeHelpYouSolve #Exponent #InternationalArbitration #InternationalDisputes #Disputes #DubaiArbitrationWeek #DAW

Consumers continue to express increasing concerns over the ecological and environmental impacts of waste in the environment, including apparel. New extended producer responsibility (EPR) legislation shifts the burden of recycling from consumers to the producers of those materials, with significant impacts for textile producers across California: https://hubs.ly/Q02X_Kr50 Hilda Buss , Alexandra Gobeil, Ph.D. , Erin Kirkpatrick , Jordan Pitt, PhD #Exponent #Alert #Chemicals #ConsumerProducts #TextileIndustry

Unlike traditional clinical trials, DCTs use decentralized elements — like telehealth visits and digital health technologies — that allow trial-related activities to occur remotely. Find out how stakeholders can best integrate decentralized components into clinical trials. https://hubs.li/Q02Wl99d0 Erica Lively , Marta Villarraga, PhD, RAC , Bo Qing , Megan Leonhard , #Exponent #Alert #LifeSciences #ClinicalTrials #RegulatoryAffairs #DigitalHealth

Pursuing your passions is an integral part of working at Exponent. Our employees are regularly engaged in meaningful work that helps our clients solve problems that directly impact health, safety, and sustainability around the globe. Learn more: https://hubs.li/Q02XYHC80 Catherine Rogers Murray, MPH #Exponent #ImpactExponentially

We're #hiring a new Senior Facilities Specialist in Natick, Massachusetts. Apply today or share this post with your network.

Working at Exponent provides the opportunity to thrive in an environment where entrepreneurial spirit is recognized, and inclusivity is foundational. Learn more: https://hubs.li/Q02W9W930 #Exponent #ImpactExponentially

Engineering and construction management curricula in post-secondary institutions provide the perfect forum for integrating and progressing new and advanced pedagogies, specifically around project controls. At the 17th annual International Conference of Education, Research and Innovation (ICERI), Exponent’s Dr. Nakisa (Niki) Alborz, LEED AP BDC, PMP , will present “Infusing New and Advanced Pedagogies in Engineering and Construction Management Curricula for Enhanced Student Engagement” Tuesday, Nov. 12, 11 a.m.-noon CET. Project controls encompass activities such as estimating costs, developing schedules, managing risk, assessing and measuring performance, and more. Currently, these knowledge areas are learned on the job, where stakes are high and room for mistakes is low — making it critical to enhance classroom training in advance of boots-on-the-ground experience. Register: https://hubs.li/Q02XNTVH0 Connect with Dr. Alborz: https://hubs.li/Q02XNX420 #Exponent #Event #ICERI2024 #ConstructionConsulting IATED

	Jan '14	Jan '15	Jan '16	Dec '16	Dec '17	Dec '18	Jan '20	Jan '21	Dec '21	Dec '22	Dec '23
revenue	296.17M -	304.70M 2.88%	312.83M 2.67%	315.08M 0.72%	347.80M 10.39%	379.52M 9.12%	417.20M 9.93%	399.90M 4.15%	466.27M 16.60%	513.29M 10.09%	536.77M 4.57%
cost of revenue	16.13M -	15.49M 3.91%	17.13M 10.53%	15.88M 7.29%	18.14M 14.21%	24.88M 37.22%	25.81M 3.72%		32.59M -	35.08M 7.64%	401.00M 1,043.02%
gross profit	280.04M -	289.21M 3.27%	295.70M 2.25%	299.20M 1.18%	329.66M 10.18%	354.64M 7.58%	391.39M 10.36%	399.90M 2.17%	433.68M 8.45%	478.21M 10.27%	135.76M 71.61%
selling and marketing expenses											-319.89M -
general and administrative expenses	198.80M -	199.38M 0.29%	199.80M 0.21%	208.89M 4.55%	228.07M 9.18%	232.58M 1.98%	272.72M 17.26%	262.93M 3.59%	293.33M 11.56%	287.89M 1.85%	344.33M 19.60%
selling general and administrative expenses	198.80M -	199.38M 0.29%	199.80M 0.21%	208.89M 4.55%	228.07M 9.18%	232.58M 1.98%	272.72M 17.26%	262.93M 3.59%	293.33M 11.56%	287.89M 1.85%	24.44M 91.51%
research and development expenses
other expenses	7.87M -	4.27M 45.81%	1.99M 53.28%	6.53M 227.55%	9.16M 40.38%	-890K 109.71%	59.37M 6,770.90%	53.72M 9.51%	64.01M 19.16%	84.56M 32.09%	3.37M 96.02%
cost and expenses	240.22M -	241.16M 0.39%	243.90M 1.14%	253.16M 3.80%	275.75M 8.92%	288.07M 4.47%	332.09M 15.28%	316.65M 4.65%	357.34M 12.85%	372.45M 4.23%	425.44M 14.23%
operating expenses	240.22M -	241.16M 0.39%	243.90M 1.14%	253.16M 3.80%	275.75M 8.92%	288.07M 4.47%	332.09M 15.28%	316.65M 4.65%	357.34M 12.85%	372.45M 4.23%	24.44M 93.44%
interest expense	-8.00M -	-4.42M 44.79%	-2.20M 50.18%	-7.21M 227.77%	-10.46M 45.03%	-1.86M 82.21%				2.10M -
ebitda	55.95M -	63.55M 13.59%	68.93M 8.47%	61.91M 10.19%	72.05M 16.38%	91.46M 26.93%	85.11M 6.94%	83.25M 2.19%	108.93M 30.84%	140.84M 29.30%	120.24M 14.63%
operating income	55.95M -	63.55M 13.59%	68.93M 8.47%	61.91M 10.19%	72.05M 16.38%	91.46M 26.93%	85.11M 6.94%	83.25M 2.19%	108.93M 30.84%	140.84M 29.30%	111.32M 20.96%
depreciation and amortization	4.95M -	5.40M 9.15%	5.48M 1.39%	6.13M 11.90%	6.29M 2.51%	6.29M 0.11%	6.81M 8.17%	6.87M 0.96%	6.49M 5.59%	7.08M 9.13%	8.92M 25.95%
total other income expenses net	7.87M -	4.27M 45.81%	1.99M 53.28%	6.53M 227.55%	9.16M 40.38%	-890K 109.71%	19.08M 2,243.71%	13.69M 28.26%	16.91M 23.55%	-8.61M 150.90%	24.57M 385.48%
income before tax	63.95M -	67.97M 6.29%	71.13M 4.66%	69.12M 2.83%	82.51M 19.37%	93.32M 13.10%	104.19M 11.65%	96.94M 6.96%	125.84M 29.81%	132.23M 5.08%	135.90M 2.77%
income tax expense	25.30M -	27.26M 7.74%	27.53M 0.99%	21.64M 21.40%	41.20M 90.39%	21.06M 48.88%	21.73M 3.17%	14.38M 33.81%	24.64M 71.27%	29.90M 21.39%	35.56M 18.90%
net income	38.64M -	40.70M 5.33%	43.60M 7.12%	47.48M 8.90%	41.30M 13.01%	72.25M 74.93%	82.46M 14.13%	82.55M 0.11%	101.20M 22.59%	102.33M 1.11%	100.34M 1.95%
weighted average shs out	54.46M -	53.82M 1.18%	53.21M 1.13%	52.98M 0.44%	52.72M 0.48%	52.91M 0.35%	52.69M 0.41%	52.39M 0.58%	52.61M 0.42%	51.73M 1.68%	51.15M 1.11%
weighted average shs out dil	56.10M -	55.33M 1.37%	54.60M 1.33%	54.33M 0.48%	53.97M 0.66%	54.17M 0.36%	53.88M 0.52%	53.32M 1.04%	53.33M 0.02%	52.28M 1.97%	51.63M 1.23%
eps	0.71 -	0.76 7.04%	0.82 7.89%	0.90 9.76%	0.78 13.33%	1.37 75.64%	1.56 13.87%	1.58 1.28%	1.92 21.52%	1.98 3.13%	1.96 1.01%
epsdiluted	0.69 -	0.74 7.25%	0.80 8.11%	0.87 8.75%	0.77 11.49%	1.33 72.73%	1.53 15.04%	1.55 1.31%	1.90 22.58%	1.96 3.16%	1.94 1.02%

COM:EXPONENT

Exponent

Last Close

95.87

22/11 21:00

Market Cap

4.82B

Beta: -

Volume Today

192.16K

Avg: -

Preview